(NASDAQ: ACCD) Accolade's forecast annual revenue growth rate of 10.44% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 8.76%, and it is also forecast to beat the US market's average forecast revenue growth rate of 8.9%.
Accolade's revenue in 2024 is $441,028,000.On average, 7 Wall Street analysts forecast ACCD's revenue for 2025 to be $37,479,863,068, with the lowest ACCD revenue forecast at $37,111,486,464, and the highest ACCD revenue forecast at $37,699,407,148. On average, 7 Wall Street analysts forecast ACCD's revenue for 2026 to be $42,380,302,775, with the lowest ACCD revenue forecast at $40,735,655,064, and the highest ACCD revenue forecast at $43,127,606,340.
In 2027, ACCD is forecast to generate $47,980,609,707 in revenue, with the lowest revenue forecast at $45,205,463,004 and the highest revenue forecast at $50,021,580,388.